CareRx Corporation
TSX:CRRX.TOMedical - Care Facilities
Healthcare
$3.21 +0.63%
+$0.02 today
- Market cap
- $203.06M
- Beta
- 0.62
- P/E (TTM)
- 7.4
- EPS (TTM)
- $0.43
- Dividend yield
- 1.88%
52W Low $2.70High $4.00
Volume 0.01M
Average 0.04M
Cash Flow
Check whether earnings turn into cash.
Operating Cash Flow
$27.54M
FY 2025 · Annual
-27.5% YoYInvesting Cash Flow
-$8.26M
FY 2025 · Annual
Financing Cash Flow
-$14.44M
FY 2025 · Annual
Cash Flow Statement
CAD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (22.73M) | (34.35M) | (5.41M) | (4.5M) | 26.13M |
| Depreciation & Amortization | 15.39M | 20.07M | 19.98M | 19.19M | 18.33M |
| Deferred Income Tax | (1.01M) | (1.54M) | (4.19M) | 32K | (22.77M) |
| Stock-Based Compensation | 2.67M | 4.57M | 1.47M | 3.65M | 2.72M |
| Change in Working Capital | (3.73M) | 638K | 2.12M | 8.98M | (988K) |
| Accounts Receivables | (11.72M) | 1.51M | 1.47M | 3.82M | 247K |
| Inventory | (2.83M) | (2M) | 648K | 1.55M | (126K) |
| Accounts Payables | 15M | 816K | (181K) | 3.46M | (891K) |
| Other Working Capital | (4.17M) | 307K | 186K | 145K | (218K) |
| Other Non-Cash Items | 16.67M | 32.96M | 13.4M | 10.64M | 4.12M |
| Operating Cash Flow | 7.27M | 22.33M | 27.38M | 37.99M | 27.54M |
| Capital Expenditures | (7.12M) | (13.61M) | (8.7M) | (8.11M) | (5.59M) |
| Acquisitions (Net) | (86.13M) | (2.99M) | (3.66M) | 196K | 39K |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 67K | (3.57M) | (3.93M) | (2.53M) | 0 |
| Investing Cash Flow | (93.18M) | (16.6M) | (12.31M) | (7.92M) | (8.26M) |
| Debt Repayment | 30.35M | (5.29M) | (39.82M) | (21.58M) | (4.32M) |
| Common Stock Issued | 80.86M | 1.01M | 14.68M | 0 | 14K |
| Common Stock Repurchased | 0 | 0 | (56K) | (801K) | (2.24M) |
| Dividends Paid | 0 | 0 | 0 | 0 | (1.26M) |
| Other Financing Activities | (9.3M) | (8.71M) | (11.2M) | (5.64M) | (6.64M) |
| Financing Cash Flow | 101.91M | (12.99M) | (36.4M) | (28.02M) | (14.44M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 16M | (7.25M) | (21.34M) | 2.06M | 4.84M |
| Free Cash Flow | 153K | 8.72M | 18.68M | 29.88M | 21.95M |
Free Cash Flow
Net Income to FCF bridge
FY2025
= Net Income$26.1M
+ D&A$18.3M
+ Stock-Based Comp$2.7M
- Deferred Tax-$22.8M
- Working Capital-$988.0K
+ Other Non-Cash$4.1M
= Operating Cash Flow$27.5M
- Capex-$5.6M
= Free Cash Flow$22.0M
Analysis
FY2025 free cash flow is $22.0M. FCF conversion is 84.0% of net income. Operating cash flow was $27.5M, with capex of -$5.6M. The largest bridge item is Deferred Tax at -$22.8M.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
No filings found.
Does CRRX.TO generate free cash flow?
CareRx Corporation (CRRX.TO) generated $21.95M of free cash flow in fiscal 2025.
How much operating cash flow does CRRX.TO produce?
Operating cash flow was $27.54M, before capital expenditures of $5.58M.
Continue the stock analysis
Jump to another research area for this company.